MedTrace Logo

Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

NCT04865133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2024-12-10

No results posted yet for this study

Summary

This study gathers information about how a cancer patient responds to COVID-19 vaccine during cancer treatment compared to healthy individuals. The information gained may help determine how effective currently available COVID-19 vaccines are in cancer patients receiving chemotherapy and learn more regarding how long an immune response will last compared to healthy individuals.

Conditions

  • COVID-19 Infection
  • Malignant Solid Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Electronic Health Record Review

Medical record reviewed

Sponsors & Collaborators

Principal Investigators

  • Saranya Chumsri, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-09-08
Completion
2022-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865133 on ClinicalTrials.gov